Log in to save to my catalogue

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6058a154f53c4fd0b938c4c0b34ec507

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other conditions, such as Alzheimer’s or Parkinson’s di...

Alternative Titles

Full title

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6058a154f53c4fd0b938c4c0b34ec507

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6058a154f53c4fd0b938c4c0b34ec507

Other Identifiers

ISSN

2047-9158

E-ISSN

2047-9158

DOI

10.1186/s40035-022-00299-w

How to access this item